RATIONALE: Both prenatal and postnatal passive smoking have been linked with respiratory symptoms and asthma in childhood. Their differential contributions to lung function growth in the general children's population are less clear. OBJECTIVE: To study the relative impact of pre- and postnatal exposure on respiratory functions of primary school children in a wide range of geographic settings, we analyzed flow and volume data of more than 20,000 children (aged 6-12 yr) from nine countries in Europe and North America. METHODS: Exposure information had been obtained by comparable questionnaires, and spirometry followed a protocol of the American Thoracic Society/European Respiratory Society. Linear and logistic regressions were used, controlling for individual risk factors and study area. Heterogeneity between study-specific results and mean effects were estimated using meta-analytic tools. MAIN RESULTS: Smoking during pregnancy was associated with decreases in lung function parameters between -1% (FEV1) and -6% maximal expiratory flow at 25% of vital capacity left (MEF25). A 4% lower maximal midexpiratory flow (MMEF) corresponded to a 40% increase in the risk of poor lung function (MMEF < 75% of expected). Associations with current passive smoking were weaker though still measurable, with effects ranging from -0.5% (FEV1) to -2% maximal expiratory flow (MEF50). CONCLUSIONS: Considering the high number of children exposed to maternal smoking in utero and the even higher number exposed to passive smoking after birth, this risk factor for reduced lung function growth remains a serious pediatric and public health issue.
RATIONALE: Both prenatal and postnatal passive smoking have been linked with respiratory symptoms and asthma in childhood. Their differential contributions to lung function growth in the general children's population are less clear. OBJECTIVE: To study the relative impact of pre- and postnatal exposure on respiratory functions of primary school children in a wide range of geographic settings, we analyzed flow and volume data of more than 20,000 children (aged 6-12 yr) from nine countries in Europe and North America. METHODS: Exposure information had been obtained by comparable questionnaires, and spirometry followed a protocol of the American Thoracic Society/European Respiratory Society. Linear and logistic regressions were used, controlling for individual risk factors and study area. Heterogeneity between study-specific results and mean effects were estimated using meta-analytic tools. MAIN RESULTS: Smoking during pregnancy was associated with decreases in lung function parameters between -1% (FEV1) and -6% maximal expiratory flow at 25% of vital capacity left (MEF25). A 4% lower maximal midexpiratory flow (MMEF) corresponded to a 40% increase in the risk of poor lung function (MMEF < 75% of expected). Associations with current passive smoking were weaker though still measurable, with effects ranging from -0.5% (FEV1) to -2% maximal expiratory flow (MEF50). CONCLUSIONS: Considering the high number of children exposed to maternal smoking in utero and the even higher number exposed to passive smoking after birth, this risk factor for reduced lung function growth remains a serious pediatric and public health issue.
Authors: Guadalupe Ortega; Cristina Castellà; Carlos Martín-Cantera; Jose L Ballvé; Estela Díaz; Marc Saez; Juan Lozano; Lourdes Rofes; Concepció Morera; Antònia Barceló; Carmen Cabezas; Jose A Pascual; Raúl Pérez-Ortuño; Esteve Saltó; Araceli Valverde; Mireia Jané Journal: BMC Public Health Date: 2010-12-20 Impact factor: 3.295
Authors: Robyn T Cohen; Benjamin A Raby; Kristel Van Steen; Anne L Fuhlbrigge; Juan C Celedón; Bernard A Rosner; Robert C Strunk; Robert S Zeiger; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2010-07-31 Impact factor: 10.793
Authors: Shakira Franco Suglia; Louise Ryan; Francine Laden; Douglas W Dockery; Rosalind J Wright Journal: Psychosom Med Date: 2007-12-24 Impact factor: 4.312
Authors: Gina S Lovasi; Ana V Diez Roux; Eric A Hoffman; Steven M Kawut; David R Jacobs; R Graham Barr Journal: Am J Epidemiol Date: 2009-11-25 Impact factor: 4.897